To determine the potential effects of fibroblast‐released FGF7 in EC, we investigated the influence of EC patient‐derived cancer‐associated fibroblasts (CAFs67) on the migration of invasive FGFR2‐mutant EC cells. Here, FGFR2 is linked to cancer.